FDA Inspection 1248982 — Angela L. Gentile, M.D.
The FDA completed an inspection of Angela L. Gentile, M.D. on August 23, 2024 in Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 23, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Buenos Aires (Argentina)
Additional Details
Clinical Investigator (CI)